- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07531836
Prehabilitación Multicomponente en Adultos Mayores con Cáncer de Mama (PREHAB-BC65)
Multidimensional Oncogeriatric Prehabilitation in Older Adults With Breast Cancer: A Randomized Controlled Trial Integrating Frailty and Biomarker Assessment
Older adults with breast cancer frequently present with frailty, decreased functional reserve, and increased risk of postoperative complications. Prehabilitation programs have emerged as a promising strategy to improve physical function and clinical outcomes; however, evidence in geriatric oncology remains limited, particularly regarding the role of biological markers in predicting response to such interventions.
This study aims to evaluate the effectiveness of a multicomponent prehabilitation program in older adults with breast cancer, focusing on functional status, clinical outcomes, and quality of life. In addition, the study seeks to characterize biological markers associated with frailty and treatment response, with the goal of identifying potential predictors of benefit from prehabilitation.
Participants will undergo a structured prehabilitation intervention including physical exercise, nutritional optimization, and comprehensive geriatric assessment. Clinical, functional, and biomarker data will be collected longitudinally.
The results of this study may contribute to improving personalized care strategies in geriatric oncology and to identifying patients who are most likely to benefit from prehabilitation programs.
Descripción general del estudio
Estado
Descripción detallada
This study is a prospective, randomized, controlled, single-blind clinical trial designed to evaluate the effectiveness of a multicomponent prehabilitation program in older adults with breast cancer, incorporating biological characterization to explore predictors of treatment response.
The trial will be conducted at the Navarre University Hospital (Pamplona, Spain). A total of 90 ambulatory patients aged 65 years or older with a confirmed diagnosis of breast cancer will be recruited and randomly assigned in a 1:1:1 ratio to usual care, a home-based multicomponent exercise program based on the Vivifrail methodology, or a supervised hospital-based intervention. All participants will undergo baseline frailty screening followed by a comprehensive geriatric assessment to characterize functional, cognitive, nutritional, and clinical status. Assessments will be repeated at predefined time points throughout the perioperative period and during follow-up.
The intervention is structured into preoperative and postoperative phases and includes individualized multicomponent exercise, nutritional optimization, and targeted management of geriatric syndromes. The hospital-based intervention consists of supervised sessions over six weeks (including a 2-week preoperative phase and a 4-week postoperative phase), while the home-based intervention is adapted to baseline functional status.
Clinical, functional, and biological data will be collected longitudinally to evaluate the impact of the intervention and to identify predictors of clinical outcomes and treatment response.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Marta Lorente Escudero, MD
- Número de teléfono: +34 648148503
- Correo electrónico: marta.lorente.escudero@navarra.es
Copia de seguridad de contactos de estudio
- Nombre: Nicolás Martínez Velilla, PhD
- Número de teléfono: +34 670900434
- Correo electrónico: nicolas.martinez.velilla@navarra.es
Ubicaciones de estudio
-
-
Navarre
-
Pamplona, Navarre, España, 31008
- Reclutamiento
- Hospital Universitario de Navarra
-
Contacto:
- Marta Lorente Escudero, MD
- Número de teléfono: +34 648148503
- Correo electrónico: marta.lorente.escudero@navarra.es
-
Contacto:
- Nicolás Martínez Velilla, MD, PhD
- Número de teléfono: +34 670900434
- Correo electrónico: nicolas.martinez.velilla@navarra.es
-
Investigador principal:
- Nicolás Martínez Velilla, MD, PhD
-
Sub-Investigador:
- Bernardo Abel Cedeño Veloz, MD, PhD
-
Sub-Investigador:
- Susana de la Cruz Sánchez, MD
-
Sub-Investigador:
- Sara Esteban Gordillo, MD
-
Sub-Investigador:
- Natalia Moras Pérez, MD
-
Sub-Investigador:
- Fabricio Zambom Ferraresi, PhD
-
Sub-Investigador:
- Marta Lorente Escudero, MD
-
Sub-Investigador:
- Lucía Lozano Vicario, MD, PhD
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Age ≥65 years
- Diagnosis of breast cancer requiring elective surgery with curative intent
- Candidate for prehabilitation program before surgery
- Ability to walk (with or without assistive devices)
- Ability to provide informed consent
Exclusion Criteria:
- Urgent or emergency surgery
- Severe cognitive impairment precluding participation in the intervention
- Severe functional dependency (e.g., bedridden patients)
- Medical contraindication to physical exercise
- Life expectancy <3 months
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Usual Care
Participants receive standard clinical care according to routine practice, including management by oncology and surgical teams. Identified geriatric conditions are communicated to the treating physician for appropriate management. |
|
|
Experimental: Home-based Multicomponent Prehabilitation (Vivifrail)
Participants perform a home-based multicomponent exercise program based on the Vivifrail methodology, including strength, endurance, balance, and flexibility training over six weeks, comprising a 2-week preoperative phase and a 4-week postoperative phase. The program is tailored according to baseline functional status and supported by caregiver supervision. Participants also receive comprehensive geriatric assessment and nutritional optimization. |
Participants perform a structured home-based multicomponent exercise program based on the Vivifrail methodology, including strength, endurance, balance, and flexibility training over six weeks. The program is individualized according to baseline functional status. Participants undergo comprehensive geriatric assessment with targeted interventions including nutritional optimization, medication review, and management of geriatric syndromes. |
|
Experimental: Supervised Multicomponent Prehabilitation
Participants receive a supervised multicomponent exercise program delivered in the hospital setting, including aerobic, resistance, balance, and flexibility training over six weeks, including a 2-week preoperative phase and a 4-week postoperative phase. The intervention is combined with comprehensive geriatric assessment, nutritional optimization, and individualized management of geriatric syndromes. |
Participants undergo comprehensive geriatric assessment with targeted interventions including nutritional optimization, medication review, and management of geriatric syndromes. Participants receive a structured, supervised multicomponent exercise program delivered in a hospital setting, including aerobic, strength, balance, and flexibility training over six weeks. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in physical function assessed by Short Physical Performance Battery (SPPB)
Periodo de tiempo: Baseline to the end of the 6-week intervention period
|
Physical function will be assessed using the Short Physical Performance Battery (SPPB), a validated tool in older adults (score range 0-12, higher scores indicate better performance). The primary outcome will be the change in SPPB score from baseline to the end of the 6-week intervention period. |
Baseline to the end of the 6-week intervention period
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Incidence of postoperative complications
Periodo de tiempo: Within 30 days after surgery
|
Occurrence of postoperative complications within 30 days after surgery, classified according to the Clavien-Dindo classification. |
Within 30 days after surgery
|
|
Length of hospital stay
Periodo de tiempo: From date of surgery until hospital discharge, with a maximum follow-up of 30 days postoperatively
|
Number of days from surgery to hospital discharge. |
From date of surgery until hospital discharge, with a maximum follow-up of 30 days postoperatively
|
|
Functional decline after surgery
Periodo de tiempo: Baseline to 30 days after surgery
|
Functional decline defined as a decrease in the Short Physical Performance Battery (SPPB) score (range 0 to 12, with higher scores indicating better physical performance) or loss of independence in activities of daily living compared to baseline. |
Baseline to 30 days after surgery
|
|
Health-related quality of life
Periodo de tiempo: Baseline to 30 days after surgery
|
Health-related quality of life assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30; scores transformed to a 0-100 scale, where higher scores indicate better functioning or worse symptoms depending on the domain). |
Baseline to 30 days after surgery
|
|
Adherence to the intervention
Periodo de tiempo: During the 6-week intervention period
|
Percentage of prescribed exercise sessions completed by participants. |
During the 6-week intervention period
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Director de estudio: Marta Lorente Escudero, MD, Navarre Health Service (SNS-O), Navarre University Hospital (HUN), Pamplona, Spain
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Manifestaciones neurológicas
- Enfermedades del Sistema Nervioso
- Manifestaciones Neuromusculares
- Procesos Patológicos
- Neoplasias por sitio
- Neoplasias
- Condiciones Patológicas, Anatómicas
- Enfermedades de la piel
- Enfermedades de los senos
- Atrofia Muscular
- Atrofia
- Condiciones Patológicas, Signos y Síntomas
- Enfermedades de la piel y del tejido conectivo
- Signos y síntomas
- Fragilidad
- Neoplasias de mama
- Sarcopenia
- Calidad, acceso y evaluación de la atención médica
- Técnicas de investigación
- Métodos epidemiológicos
- Recopilación de datos
- Mecanismos de evaluación de atención médica
- Calidad de la atención médica
- Salud pública
- Medio ambiente y salud pública
- Características de la población
- Estado de salud
- Demografía
- Mediciones epidemiológicas
- Evaluación geriátrica
Otros números de identificación del estudio
- HUN-PREHAB-BC-65
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Individual participant data will not be shared due to data protection regulations and institutional policies. De-identified data may be available from the corresponding author upon reasonable request, subject to ethical approval and data sharing agreements.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .